Pharmaceutical major Dr Reddy's Labs has reported a better than expected consolidated net profit number at Rs 308 crore, an increase of 7.4% for the second quarter of FY12 as against Rs 286.8 crore in the corresponding quarter last fiscal.
G V Prasad, VC & CEO, Dr Reddy's Laboratories tells CNBC-TV18 that North America, Russia and the Pharmaceuticals Services and Active Ingredients (PSAI) segment led to the stupendous growth in the business. Below is an edited transcript of his interview. Watch the accompanying video for more. Q: Could you just take us through the contribution from the old products that already exist for Dr. Reddy
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
